All Type of News
Expansion of Domestic Pharmaceutical Exports to Advanced Countries
The export sales of bulk and finished pharmaceuticals that are manufactured by domestic companies are currently being expanded into the advanced countries in the world, including the United States, Europe, and Japan, ...
First GMP Accreditation Obtained by Nutraceutical Company
Natural Food & Pharmaceuticals Corp., a domestic maker specialized in nutraceutical products, announced last week that it has successfully received a GMP (Good Manufacturing Practice) certification from the Korea Food...
Green Cross Plans to Launch Mass Production of Human Placenta Injectable Preparations
Green Cross Holdings and Japan Bioproducts Industry Co. Ltd (Tokyo, Japan) recently agreed to form a joint venture to launch a domestic mass production of human placenta injectable preparations, with an expected start...
MOHW Prepares Full Assessment on Separation Law
The Ministry of Health and Welfare (MOHW) is reported to announce a detailed roadmap plan during the month of March, under its current initiative of making assessments on the regulation for separation of dispensary fr...
Dong-A Introduces Upgraded Version of Bacchus
Dong-A Pharmaceutical announced of its plan to introduce Bacchus-D, an upgraded version of existing Bacchus-F, an over-the-counter (OTC) tonic drink with high recognition and popularity in the domestic market.
The ...
All KGMP Certified Manufacturers Subject to Evaluation
The Korea Food and Drug Administration (KFDA) made an official announcement this week to launch a joint assessment review on 226 KGMP (Korea Good Manufacturing Practice) certified manufacturers of pharmaceutical produ...
Zuellig Denies Proposal on Inventory Returns from Its Associate Wholesalers
In the third round of negotiations on improving contractual terms and conditions for the pharmaceutical wholesale distribution by Zuellig Pharma Korea (ZPK), the representatives from the Seoul Pharmaceutical Associati...
Domestic Unavailability of Taxol 100mg Explained
It is reported that a recent decision by the Seoul National University Hospital (SNUH) to remove BMS Korea's anticancer drug Taxol from the list of prescription medications was due to an unmet request for Taxol availa...
Compulsory Bioequivalence Testing Requirement under Further Deliberation
As the industry constituents has essentially reached a general consensus on the enforcement of small-unit packaging requirement for pharmaceutical products in a periodic rollout scheme, the compulsory bioequivalence t...
Favorable Insurance Pricing for Bioequivalent Generics Now Terminated
Effective February 22nd, the generic drugs approved for their bioequivalance are no longer subject to the favorable pricing provision by the government, in which their registrations to the National Health Insurance (N...
